The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223.
Datadog
DDOG · a US exchange · USD · Market cap $75.5B · 8,100 employees
Datadog, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 23:00 UTC · 17 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Datadog holds its Distribution at $210.23. Elevated stress, defensive posture warranted, held for 51 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 51 days |
| Price at the screen | $210.23 |
| Valuation | 429.04 trailing · 70.82 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.49 |
Five Screens, Shown in Full
Does not pass. Interest-bearing securities
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 19.25% | Below 33% | Interest-bearing debt is just 19.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 61.31% | Below 33% | Interest-bearing cash and securities are 61.3% of assets, above the one-third limit. | Fail |
| Receivables | 17.20% | Below 49% | Money owed to the company is 17.2% of assets, under the 49% limit. | Pass |
| Revenue purity | 5.67% | Below 5% | 5.7% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $186.09 fair value estimate, weak competitive moat, 35.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 11.5% above the base estimate.
Third-party analyst targets: 46 covering, consensus Strong Buy. The average target sits +40% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCloud Monitor Trades Well Beyond Its Worth
Every developer chasing uptime in the cloud ends up feeding logs and metrics into Datadog. Yet the business sits on a weak moat, slim 4 percent profit margins and just 4 percent return on equity, while revenue growth of 32 percent fails to justify an 89.8 times forward earnings multiple.
We pass because the shares trade at a 36 percent premium to fair value and the company fails our ethical screen on interest-bearing securities. Analyst consensus calls for strong buy at the current price, yet the numbers show a business that has not yet proved durable pricing power or consistent cash returns.
High valuation leaves little room for any slowdown in cloud spending, and the ethical flag removes it from consideration entirely. Analysis, not advice.
| Forward P/E | 70.8xpriced for continued growth |
| Trailing P/E | 429.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.49 |
| EPS, forward | 2.97 |
| Revenue growth | +35.6%strong top-line growth |
| Profit margin | 4.5%barely profitable |
| Return on equity | 4.7%a modest return on shareholder capital |
| FCF yield | 1.39% |
| Debt to equity | 0.29minimal debt: a conservative balance sheet |
| Current ratio | 3.21comfortably covers its short-term bills |
| Beta | 1.49moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 98.01 - 292.72 |
| Moat | WEAK |
| Market cap | $75.5B |
| Employees | 8,100 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDDOG trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 92%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (47 analysts) rates it strong buy, with a mean price target of $223.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Google Holds Top Rating Investor's Business Daily · 18 Jul 2026
- The Real Engine Behind ServiceNow Stock Is Its Contract Backlog Trefis · 17 Jul 2026
- Datadog CEO Olivier Pomel Sells 127,000 Shares for $32.9 Million Motley Fool · 17 Jul 2026
- Datadog (DDOG) Recognized By Gartner Again As AI Observability Lead Continues Simply Wall St. · 16 Jul 2026
- Datadog (DDOG) Stock Dips While Market Gains: Key Facts Zacks · 15 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | LE-QUOC ALEXIS T | Chief Technology Officer | 43,224 | · | |
| 2026-05-18 | LE-QUOC ALEXIS T | Chief Technology Officer | 43,224 | $8,992,461 | |
| 2026-05-15 | CALLAHAN MICHAEL JAMES | Director | 2,500 | · | |
| 2026-05-12 | CALLAHAN MICHAEL JAMES | Director | 5,000 | · | |
| 2026-05-11 | AGARWAL AMIT | Director | 20,000 | · | |
| 2026-05-11 | POMEL OLIVIER | Chief Executive Officer | 127,141 | · | |
| 2026-05-11 | POMEL OLIVIER | Chief Executive Officer | 127,141 | $25,408,082 | |
| 2026-05-11 | AGARWAL AMIT | Director | 20,000 | $4,002,637 | |
| 2026-05-08 | JACOBSON MATTHEW | Director | 52,832 | $9,999,891 | |
| 2026-05-08 | RICHARDSON JULIE G | Director | 4,363 | $817,253 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 27 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $202.32 | +13.6% | · | $1,136 | +13.6% |
| 2 months | $105.37 | +118.1% | · | $2,181 | +118.1% |
| 3 months | $127.16 | +80.7% | · | $1,807 | +80.7% |
| 6 months | $149.90 | +53.3% | · | $1,533 | +53.3% |
| 1 year | $119.91 | +91.6% | · | $1,916 | +91.6% |
| 2 years | $112.99 | +103.4% | · | $2,034 | +103.4% |
| 3 years | $95.63 | +140.3% | · | $2,403 | +140.3% |
| 5 years | $95.48 | +140.7% | · | $2,407 | +140.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DDOG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.